Defence Announces US Molecular and Antibody Research Expert Dr. Elias Theodorou Joins Defence's Management Team as Chief Operating Officer #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #CSEStocks #OTC #OTCMarkets #OTCStocks #SmallCaps #Investing
Montreal, Quebec--(Newsfile Corp. - March 26, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing radiopharmaceuticals and ADC products using its proprietary platform and drug delivery technologies in addition to novel immune-oncology vaccines, is pleased to announce that Dr. Elias Theodorou is joining the management team as the Chief Operating Officer "COO", effective in April, 2025. Dr. Elias...
http://dlvr.it/TJlq6P
http://dlvr.it/TJlq6P
Comments
Post a Comment